Camel's Milk as a Safe Alternative in Cow's Milk Allergy

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Meir Medical Center

ClinicalTrials.gov Identifier:

NCT01223885

First received: October 10, 2010

Last updated: October 7, 2015

Last verified: August 2012

History of Changes

Purpose

By performing a challenge with camel's milk in patients who are allergic to cow's milk, the investigators will examine if camel's milk is a safe alternative for these patients.

Condition	Intervention
Cow's Milk Allergy	Dietary Supplement: Camel's milk


Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Allergy

U.S. FDA Resources

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:

Development of allergic symptoms after graded oral challenge with camel's milk [ Time Frame: 3 hours follow-up after completion of the challenge ]


Estimated Enrollment:	30
Study Start Date:	December 2010
Study Completion Date:	February 2013
Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Camel's milk, Cow's milk allergy	Dietary Supplement: Camel's milk Patients with proved cow's milk allergy who have negative prick skin tests to came's milk will be administered gradually increased doses of pasteurized camel's milk at 30 minute intervals

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Proved cow"s milk allergy

Exclusion Criteria:

Pregnant women

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01223885

Locations


Israel
Allergy Unit, Meir Medical Center
Kfar-Saba, Israel, 44281

Sponsors and Collaborators

Meir Medical Center

More Information


Responsible Party:	Meir Medical Center
ClinicalTrials.gov Identifier:	NCT01223885 History of Changes
Other Study ID Numbers:	CM-MK-2
Study First Received:	October 10, 2010
Last Updated:	October 7, 2015

Additional relevant MeSH terms:


Hypersensitivity Milk Hypersensitivity Immune System Diseases Food Hypersensitivity Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on June 22, 2017

To Top